Trevi Therapeutics
TRVI
#5339
Rank
C$1.99 B
Marketcap
C$15.53
Share price
-0.27%
Change (1 day)
170.07%
Change (1 year)

Earnings for Trevi Therapeutics (TRVI)

Earnings in 2025 (TTM): -C$64.47 Million

According to Trevi Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$66.61 Million a decrease over its 2023 earnings that were of -C$39.89 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevi Therapeutics from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$64.47 Million-3.2%
2024 -C$66.61 Million67%
2023 -C$39.89 Million2.43%
2022 -C$38.94 Million-14.45%
2021 -C$45.52 Million1.36%
2020 -C$44.91 Million23.64%
2019 -C$36.32 Million27.54%
2018 -C$28.48 Million